Previous Section
General Interest Articles
1. Chronic myelogenous leukemia.
- Author
- O'brien S; Berman E; Bhalla K; Copelan EA; Devetten MP; Emanuel PD; Erba HP; Greenberg PL; Moore JO; Przepiorka D; Radich JP; Schilder RJ; Shami P; Smith BD; Snyder DS; Soiffer RJ; Tallman MS; Talpaz M; Wetzler M;
- Institution
- Journal
- J Natl Compr Canc Netw. 2007 May;5(5):474-96.
2. Chronic myelogenous leukemia: ESMO Clinical Recommendations for diagnosis, treatment and follow-up.
- Author
- Institution
- Journal
- Ann Oncol. 2007 May;18 Suppl 2:ii51-ii52.
3. Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
- Author
- Ault P; Kantarjian H; O'Brien S; Faderl S; Beran M; Rios MB; Koller C; Giles F; Keating M; Talpaz M; Cortes J;
- Institution
- Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX 77030, USA.
- Journal
- J Clin Oncol. 2006 Mar 1;24(7):1204-8. Epub 2006 Jan 30.
- Abstract URL
- Click here to view abstract
4. Monitoring Chronic Myelogenous Leukemia in the Age of Tyrosine Kinase Inhibitors.
- Author
- Radich JP; Oehler V;
- Institution
- From the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Correspondence: Jerald P. Radich, MD, Clinical Research Division, Fred Hutchinson Cancer Research Center, D4-100, 1100 Fairview Avenue North, Seattle, WA 98109. E-mail: jradich@fhcrc.org.
- Journal
- J Natl Compr Canc Netw. 2007 May;5(5):497-504.
- Abstract URL
- Click here to view abstract
5. Diagnosis and management of chronic myeloid leukemia: a survey of American and European practice patterns.
- Author
- Kantarjian HM; Cortes J; Guilhot F; Hochhaus A; Baccarani M; Lokey L;
- Institution
- Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. hkantarj@mdanderson.org
- Journal
- Cancer. 2007 Apr 1;109(7):1365-75.
- Abstract URL
- Click here to view abstract
6. Chronic myelogenous leukemia: ESMO clinical recommendations for the diagnosis, treatment and follow-up.
- Author
- Hochhaus A; Dreyling M;
- Institution
- III. Medizinische Klinik, Medizinische Fakultaet Mannheim, Universitaet Heidelberg, Mannheim, Germany.
- Journal
- Ann Oncol. 2008 May;19 Suppl 2:ii63-4.
7. Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML). Outcome of discontinuation of imatinib therapy after achieving a molecular remission.
- Author
- Ali, Ridvan; Ozkalemkas, Fahir; Ozcelik, Tulay; Ozkocaman, Vildan; Ozan, Ulku; Kimya, Yalcin; Koksal, Nilgun; Gulten, Tuna; Yakut, Tahsin; Tunali, Ahmet;
- Institution
- Division of Hematology, Department of Internal Medicine, Uludag University School of Medicine, Bursa, Turkey. ridvanali@uludag.edu.tr
- Journal
- Leuk Res 2005 Aug;29(8):971-3. Epub 2005 Feb 16.
- Abstract URL
- Click here to view abstract
8. Survival benefit with imatinib mesylate therapy in patients with accelerated-phase chronic myelogenous leukemia--comparison with historic experience.
- Author
- Kantarjian, Hagop; Talpaz, Moshe; O'Brien, Susan; Giles, Francis; Faderl, Stefan; Verstovsek, Srdan; Garcia-Manero, Guillermo; Shan, Jianqin; Rios, Mary Beth; Champlin, Richard; de Lima, Marcos; Cortes, Jorge;
- Institution
- Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. hkantarj@mdanderson.org
- Journal
- Cancer 2005 May 15;103(10):2099-108.
- Abstract URL
- Click here to view abstract
9. Cytogenetic testing for therapeutic indication in cancer.
- Author
- Mundle, Suneel; Noskina, Yelina;
- Institution
- Rush University Medical Center, Department of Biochemistry, Naperville, Chicago, IL 60565, USA. smundle@rush.edu
- Journal
- Expert Rev Mol Diagn 2005 Jan;5(1):23-9.
- Abstract URL
- Click here to view abstract
10. Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse.
- Author
- Marin, D; Kaeda, J; Szydlo, R; Saunders, S; Fleming, A; Howard, J; Andreasson, C; Bua, M; Olavarria, E; Rahemtulla, A; Dazzi, F; Kanfer, E; Goldman, J M; Apperley, J F;
- Institution
- Department of Haematology, Imperial College London at Hammersmith Hospital, London, UK.
- Journal
- Leukemia 2005 Apr;19(4):507-12.
- Abstract URL
- Click here to view abstract
Next: Drug Therapy
